{"title":"Assessment of anti-psychotic drug utilisation in psychiatry ward of tertiary care hospital","authors":"Manish Kumar","doi":"10.55522/jmpas.v12i1.3823","DOIUrl":null,"url":null,"abstract":"A total of 50 patients were enrolled in the study from October 2021 to April 2022. Total numbers of drugs prescribed were found to be 244 including the anti-psychotics. The total numbers of anti-psychotics prescribed were found to be 160. The ratio of anti-psychotics to the total number of drugs was found to be 65.7%. Antipsychotics were the most used drugs (69.6%) followed by multivitamins (7.37%), following them were proton pump inhibitors (5.73%), they were followed by analgesics (5.32%), following analgesics were cognition enhancers (4.9%), cognition enhancers were followed by mood stabilizers (4.09%), mood stabilizers were followed by anti-hypertensives (3.2%) which in turn were followed by anticholinergics (2.04%) and calcium+ vitamin D3 supplements (1.6%).","PeriodicalId":16445,"journal":{"name":"Journal of Medical pharmaceutical and allied sciences","volume":"54 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical pharmaceutical and allied sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55522/jmpas.v12i1.3823","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
A total of 50 patients were enrolled in the study from October 2021 to April 2022. Total numbers of drugs prescribed were found to be 244 including the anti-psychotics. The total numbers of anti-psychotics prescribed were found to be 160. The ratio of anti-psychotics to the total number of drugs was found to be 65.7%. Antipsychotics were the most used drugs (69.6%) followed by multivitamins (7.37%), following them were proton pump inhibitors (5.73%), they were followed by analgesics (5.32%), following analgesics were cognition enhancers (4.9%), cognition enhancers were followed by mood stabilizers (4.09%), mood stabilizers were followed by anti-hypertensives (3.2%) which in turn were followed by anticholinergics (2.04%) and calcium+ vitamin D3 supplements (1.6%).